Neoadjuvant endocrine therapy: Patient selection, treatment duration and surrogate endpoints
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference38 articles.
1. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus);Hind;Cochrane Database Syst Rev,2006
2. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus);Morgan;Cochrane Libr,2014
3. Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: a systematic review;Charehbili;Cancer Treat Rev,2014
4. Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer;Semiglazov;Cancer,2007
5. Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study;Alba;Ann Oncol,2012
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP;Journal of Clinical Oncology;2023-09-20
2. Biomarkers in Breast Cancer: An Old Story with a New End;Genes;2023-06-28
3. Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy;Healthcare;2023-02-01
4. PROSPECTS OF USING microRNAs AS PREDICTIVE MARKERS OF HORMONE-DEPENDENT BREAST CANCER;Oncology;2023
5. Study protocol: Randomized, open-label, non-inferiority clinical trial for evaluating the clinical and pathological response rates to neoadjuvant hormone therapy and chemotherapy in patients with luminal-subtype breast tumors;Contemporary Clinical Trials Communications;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3